Project
Cell-cell direct/indirect communication in metastatic breast cancer as a control point in oncotherapy
| Reference: | SFRH/BPD/109010/2015 |
|---|---|
| Funding organization: | Fundação para a Ciência e a Tecnologia |
| Associated institutions: | Universidade de Lisboa |
Similar Items
Cell-cell communication in metastatic breast cancer: a control point that can lead to breast cancer treatment
Exosomes as drug delivery systems in metastatic breast cancer
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
DIRECT AND INDIRECT EFFECTS OF CONTAMINANTS ON DETRITUS PROCESSING WITHIN FRESHWATER FOOD WEBS
Smart ruthenium-peptide prodrugs: a ray of hope in the battle against metastatic breast cancer
Autonomous biosensor for screening cancer biomarkers using passive Direct Methanol Fuel Cells
Non-invasive, innovative and promising strategy for early diagnosis of breast cancer through the establishment of urinary volatile metabolomic profiles of breast cancer patients as well as from breast cancer tissues and breast cancer cell lines
Fighting metastatic cancers: prime time for ruthenium
INNOVATIVE AUTONOMOUS ELECTRICAL BIOSENSOR SYNERGISTICALLY ASSEMBLED INSIDE A PASSIVE DIRECT METHANOL FUEL CELL FOR SCREENING CANCER BIOMARKERS
Unravelling and modulating the interplay between breast cancer cells and blood-brain barrier endothelial cells: a new hope to prevent brain metastasis formation
siRNA incorporation in a lipid/micelle-based nanocarrier as a strategy to restore E-cadherin expression and eradicate advanced breast cancer metastatic phenotype
Development of a meshless multiscale computational tool to numerically simulate MCF7 breast cancer line cell dynamics
GENETIC SUSCEPTIBILITY TO BREAST CANCER
Doctoral Program in Bioengineering - Cell Therapies and Regenerative Medicine - Translating Breast Cancer Immune Features Into Targeted Therapies
Design and Development of Key Materials for Intermediate Tempererature Solid Ceramic Direct Methanol Fuel Cell
EPIGENETIC AND CELL CYCLE CONTROL OF CENTROMERE INHERITANCE
EPIGENETIC AND CELL CYCLE CONTROL OF CENTROMERE INHERITANCE
Functionalized magnetoliposomes for enhanced anticancer activity of lactoferrin against triple negative breast cancer cells [2020.05781.BD]
Inhibition of bacterial plant virulence by interference with interspecies cell-cell communication.
Deconstructing gastric cancer colonization: The interplay between immune cells, gastric cancer cells and extracellular vesicles
Assessing the indirect costs of flooding as a traffic disruption on urban mobility [2020.06035.BD]
Test-strips for monitoring cancer biomarkers in point-of-care
Cancer Optical fibers: pre-Metastatic Engineered Tissues [2022.05737.PTDC]
Rab proteins as novel biomarkers in breast cancer
TACKLING COLON CANCER STEM CELLS WITH MICRORNAS
Fighting metastatic cancers: prime time for ruthenium [PTDC/QUI-QIN/28662/2017]
P-CADHERIN AS A REGULATOR OF EPITHELIAL CELL POLARITY AND STEM CELL DIVISION AND THE SIGNIFICANCE OF ITS OVEREXPRESSION IN BRCA1-ASSOCIATED BASAL-LIKE BREAST CARCINOMAS
A new vision for fuel cells: application in cancer biomarker screening
Expansion of Natural Killer cells as a complementary approach for adoptive cell therapy in advanced Colorectal Cancer’ NKAT-CRC
Expansion of Natural Killer cells as a complementary approach for adoptive cell therapy in advanced Colorectal Cancer’ NKAT-CRC
Cis-regulatory logic of the transcriptional control in neural stem cells
GRAPHY - Thiol-ene click injectable in situ forming hydrogels incorporating graphene: optimization of the polymer-related features for the immuno-photothermal therapy of metastatic breast cancer [2022.06320.PTDC]
Role of E-selectin ligands in breast cancer metastasis
Metabolic control of immune cell function during fungal infection [101130795]
Mechano-epigenetic control of neural crest collective cell migration in vivo
BrainEdition: remotely controlling gene edition in neural stem cells
Cell signaling control: mechanisms of TACE regulation during EGFR transactivation
Doctoral Program MIT Portugal Bio-Engineering Systems Exosomes from Human Mesenchymal Stem/stromal cells for the Delivery of Anticancer Peptides to treat breast cancer
MODULATION OF BASE EXCISION REPAIR PATHWAY FOR BREAST CANCER THERAPY
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Related publications
Loading publications...